Lovely Inu (LOVELY) Gets Listed On XT.COM

SINGAPORE, Sept. 3, 2022 /PRNewswire/ — XT.COM, the world’s first social-infused digital asset trading platform, is thrilled to announce its new listing of Lovely Inu ($LOVELY) under the platform’s main zone (DeFi). The token will be available for trading as a LOVELY and Tether (USDT)…

Retirement planning 2022: A good time to start

DUBAI, UAE, Sept. 3, 2022 /PRNewswire/ — It is never too early to start planning for retirement, especially if one is considering spending their golden years abroad. The world is brimming with breathtaking destinations for retirees to choose from, and those who start setting up their…

Yingli Pharma Announces First Patient Dosed in Phase 2 Trial of Linperlisib for Peripheral T Cell Lymphoma

Phase 2 study to assess efficacy and safety of once daily linperlisib in patients with advanced peripheral T/NK cell lymphoma SAN FRANCISCO, Sept. 3, 2022 /PRNewswire/ — Yingli Pharma (the “Company” or “Yingli”), a clinical stage biotechnology company developing oral small molecule drugs…

TCLE (1070.HK) Rocks IFA 2022 with World’s Largest Mini LED Smart Screen

TCL Smart Screen Ranks Second in LCD TV Market in Terms of Global Market Share HONG KONG, Sept. 3, 2022 /PRNewswire/ — IFA 2022, which will last for 5 days officially kicked off in Berlin today. TCL Electronics Holdings Limited (“TCL Electronics” or “the Company”, 01070.HK) has showcased…

Groups of up to Eight Traveling Together Can Save up to 60% with Amtrak Share Fares

Amtrak Share Fare Program Updated for Larger Groups and Bigger Discounts WASHINGTON, Sept. 2, 2022 /PRNewswire/ — Providing travelers with even more value, Amtrak has enhanced its popular Share Fare program so that now up to eight people traveling together can save big with a total…

Lexogen stellt das RiboCop rRNA Depletion Kit für Hefe vor – ein neues Bibliotheksvorbereitungskit, das die effiziente Entfernung von rRNA und anderen Transkripten ermöglicht

WIEN, 2. September 2022 /PRNewswire/ — Lexogen, ein Unternehmen für Transkriptomik und Next-Generation-Sequencing, gab heute die Veröffentlichung des neuen RiboCop rRNA Depletion Kit für Hefe bekannt. Die Gesamt-RNA besteht aus großen Mengen unerwünschter ribosomaler RNA (rRNA), die bis…

‘Smooth Podcasting’ Acquires ‘Outcomes Rocket’ in Growing Network Build: Podcast Editing, Publishing, and Hosting Powerhouse Adds Popular Healthcare Focused Show with Over 1,100 Published Episodes

‘With over two million downloads, and interviews with some of the most prestigious names in healthcare, our shift to a network will provide even broader and up-to-date coverage…’ SAN DIEGO, Sept. 2, 2022 /PRNewswire/ — Outcomes Rocket proudly announced it had been acquired by the hugely…

ATIF Holdings Congratulates Its Client Addentax Group Corp. on Its Uplist to Nasdaq, Raising $25 Million

ATIF Provided OTC Listing Advisory Services to Addentax in 2016 IRVINE, Calif., Sept. 2, 2022 /PRNewswire/ — ATIF Holdings Limited (Nasdaq: ATIF) (the “Company,” or “We”), a holding company providing business and financial consulting services in Asia and North America, is pleased to…

Kyndryl Sponsors Women in Cloud to Accelerate Economic Access for Women in Technology

“At Kyndryl we firmly believe that we’re stronger together and are thrilled to partner with WIC to further our Inclusion, Diversity and Equity (ID&E) mission and extend our impact to the WIC community of women technology entrepreneurs and professionals,” said Harish Grama, Global Cloud Practice Leader at Kyndryl.

Women in Cloud (WIC), an economic development organization dedicated to advancing ESG and gender inclusion in technology has welcomed Kyndryl, the world’s largest IT infrastructure services provider, as a sponsor to foster advocacy and strategic value for women tech entrepreneurs.

The collaboration aims to provide the WIC community with acces..

Depend® Brand Champions Third Annual Stand Strong for Men’s Health™ Initiative with Brian Austin Green to Benefit the Prostate Cancer Foundation

Incontinence is a leading side effect of prostate cancer treatment, and Depend® will donate per purchase of select Depend® products up to $350,000 to support prostate cancer research NEENAH, Wis., Sept. 1, 2022 /PRNewswire/ — The Depend® brand is igniting conversations about the…

« Previous PageNext Page »